stars 1 stars 2 stars 3

Saretius.Ltd - Integrated gold standard techniques in pharmacokinetics, pain, inflammation, metabolic and CNS disorders. Saretius is a UK-based company offering preclinical experimental services required by the drug discovery process, in a highly integrated fashion. Therapeutic areas covered are pain, inflammation, metabolic and CNS disorders as well as cardiovascular safety. We offer a unique service by integrating efficacy testing, therapeutic index, pharmacokinetics (PK) and pharmacodynamics (PD). This highly integrated approach helps to accelerate the drug discovery process and reduce risk in drug development by identifying PK/PD relationships. The appropriate level of integration is determined by the customer. In addition, we also offer consultancy services. Our customers range from small biotech to large multinational pharmaceutical companies.

Saretius Questions

The Saretius annual revenue was $1 million in 2026.

5 people are employed at Saretius.

The NAICS codes for Saretius are [325, 32541, 3254, 32].

The SIC codes for Saretius are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users